A. Baudy

发表

The power of FDG-PET to detect treatment effects is increased by glucose correction using a Michaelis constant

Simon-Peter Williams, Judith E Flores-Mercado, A. Baudy, 2012, EJNMMI Research.

Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate).

K. Hillgren, D. Mendrick, A. Baudy, 2022, ALTEX.

FDG-PET is a good biomarker of both early response and acquired resistance in BRAFV600 mutant melanomas treated with vemurafenib and the MEK inhibitor GDC-0973

N. van Bruggen, K. Hoeflich, Simon-Peter Williams, 2012, EJNMMI Research.

Non-invasive Optical Imaging of Muscle Pathology in mdx Mice Using Cathepsin Caged Near-Infrared Imaging

E. Hoffman, A. Kesari, A. Baudy, 2010, Molecular Imaging and Biology.

A Two-Tiered In Vitro Approach to De-Risk Drug Candidates for Potential Bile Salt Export Pump Inhibition Liabilities in Drug Discovery

R. Evers, F. Sistare, A. Baudy, 2020, Drug Metabolism and Disposition.

A robust in vitro screening assay to identify NF-kappaB inhibitors for inflammatory muscle diseases.

E. Hoffman, N. Saxena, A. Baudy, 2009, International immunopharmacology.

Δ-9,11 Modification of Glucocorticoids Dissociates Nuclear Factor-κB Inhibitory Efficacy from Glucocorticoid Response Element-Associated Side Effects

E. Hoffman, D. DuBois, J. Mccall, 2012, Journal of Pharmacology and Experimental Therapeutics.

Δ-9 , 11 modification of glucocorticoids dissociate NF-κ B inhibitory efficacy from GRE-associated side effects

Nagaraju, E. Hoffman, D. DuBois, 2012 .

mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells.

Anneleen Daemen, Min Gao, Marie Evangelista, 2016, Cancer cell.

mTORC 1-Dependent Meta bolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells Graphical

J. Settleman, A. Daemen, W. Sandoval, 2016 .

Restoring dystrophin expression in duchenne muscular dystrophy muscle progress in exon skipping and stop codon read through.

E. Hoffman, S. Takeda, A. Baudy, 2011, The American journal of pathology.

Noninvasive Preclinical and Clinical Imaging of Liver Transporter Function Relevant to Drug-Induced Liver Injury

J. G. Kenna, S. Sourbron, P. Hockings, 2018 .

Flow virometry for process monitoring of live virus vaccines-lessons learned from ERVEBO

R. Rustandi, A. Baudy, M. Mukherjee, 2021, Scientific Reports.

Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry.

Philip Hewitt, Jinping Gan, Terry R Van Vleet, 2019, Lab on a chip.

Pituitary adenylate cyclase-activating peptide (PACAP) induces differentiation in the neuronal F11 cell line through a PKA-dependent pathway

A. Baudy, J. Dunlop, M. Fennell, 2006, Brain Research.